• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    54 Biggest Movers From Thursday

    12/27/21 5:07:47 AM ET
    $ACHR
    $ACST
    $ALLK
    $AVCT
    Aerospace
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACHR alert in real time by email

    Gainers

    • 22nd Century Group, Inc. (NASDAQ:XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of nicotine for smokers who use them.
    • The Oncology Institute, Inc. (NASDAQ:TOI) gained 38.5% to close at $10.44.
    • Pasithea Therapeutics Corp. (NASDAQ:KTTA) shares climbed 36.7% to close at $2.01 on Thursday. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic in the UK.
    • Eliem Therapeutics, Inc. (NASDAQ:ELYM) gained 31% to settle at $14.19. Eliem Therapeutics, during November, reported a Q3 loss of $0.70 per share.
    • REE Automotive Ltd. (NASDAQ:REE) jumped 26.6% to close at $5.04. Hitachi and Ree Automotive recently agreed on collaboration to advance and simplify the adoption of sustainable electric vehicles globally.
    • Biofrontera Inc. (NASDAQ:BFRI) gained 25.4% to close at $13.17.
    • Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) jumped 24.1% to settle at $11.14.
    • Allakos Inc. (NASDAQ:ALLK) surged 22.2% to close at $10.45. Morgan Stanley maintained Allakos with an Equal-Weight and lowered the price target from $86 to $10. Allakos shares tumbled 90% on Wednesday after the company reported data from ENIGMA 2 Phase 3 study of lirentelimab in eosinophilic gastritis (EG) or eosinophilic duodenitis (EoD) and KRYPTOS Phase 2/3 study of lirentelimab in eosinophilic esophagitis (EoE).
    • Genocea Biosciences, Inc. (NASDAQ:GNCA) shares jumped 19.7% to close at $1.2450 after gaining over 7% on Wednesday.
    • Nxt-ID, Inc. (NASDAQ:NXTD) gained 19.7% to close at $4.01.
    • View, Inc. (NASDAQ:VIEW) shares climbed 19% to close at $4.57. View recently entered a strategic agreement with RXR Realty to combine the WorxWell data analytics platform into its technology stack.
    • HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) gained 18.1% to settle at $4.37. HTG recently completed HTP product next-phase development milestone.
    • Nikola Corporation (NASDAQ:NKLA) jumped 18% to close at $11.09 following a tweet by the company highlighting the delivery of its first truck to a customer.
    • TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) rose 18% to settle at $3.6450.
    • Sunlight Financial Holdings Inc. (NYSE:SUNL) gained 17% to close at $4.48.
    • BioSig Technologies, Inc. (NASDAQ:BSGM) jumped 16.9% to settle at $2.70.
    • Lightning eMotors, Inc. (NYSE:ZEV) surged 16.5% to close at $6.79.
    • Finch Therapeutics Group, Inc. (NASDAQ:FNCH) shares gained 15.8% to close at $10.79.
    • Xilio Therapeutics, Inc. (NASDAQ:XLO) jumped 15.7% to close at $16.00.
    • NextDecade Corporation (NASDAQ:NEXT) gained 15.6% to settle at $3.19.
    • New Pacific Metals Corp. (NYSE:NEWP) surged 15.5% to close at $3.42.
    • Archer Aviation Inc. (NYSE:ACHR) rose 14.5% to close at $6.86.
    • Sunlight Financial Holdings Inc. (NYSE:SUNL) jumped 17% to settle at $4.48. Sunlight Financial, last month, reported Q3 sales of $30.00 million.
    • Hyzon Motors Inc. (NASDAQ:HYZN) rose 13.6% to close at $7.08 after Canaccord Genuity initiated coverage on the stock with a Buy rating and announced a $12 price target.
    • Osmotica Pharmaceuticals plc (NASDAQ:OSMT) rose 11.3% to close at $1.18. HC Wainwright & Co. initiated coverage on Osmotica Pharmaceuticals with a Buy rating and announced a price target of $5.
    • XL Fleet Corp. (NYSE:XL) jumped 9.8% to close at $3.81.
    • Scientific Games Corporation (NASDAQ:SGMS) climbed 9% to close at $67.75 after the company announced it has withdrew its offer to acquire the remaining 19% equity interest in SciPlay.
    • uCloudlink Group Inc. (NASDAQ:UCL) climbed 8.9% to close at $3.30.
    • Energy Focus, Inc. (NASDAQ:EFOI) gained 8.7% to close at $4.02.
    • Bright Health Group, Inc. (NYSE:BHG) gained 7.1% to close at $3.76. Morgan Stanley recently downgraded Bright Health from Equal-Weight to Underweight and lowered the price target from $5 to $4.
    • Sigilon Therapeutics, Inc. (NASDAQ:SGTX) gained 7.1% to close at $3.00. Canaccord Genuity maintained Sigilon Therapeutics with a Buy and lowered the price target from $12 to $7.
    • ESS Tech, Inc. (NYSE:GWH) gained 6.6% to close at $13.50. Baird recently initiated ESS Tech with an Outperform rating and a price target of $15, implying an upside of 17.6%.


    Check out these big penny stock gainers and losers

    Losers

    • InnovAge Holding Corp. (NASDAQ:INNV) shares fell 35.6% to close at $5.31 on Thursday. The Centers for Medicare and Medicaid Services (CMS) has determined to suspend new enrollments at InnovAge Holding’s Colorado centers based on deficiencies detected in an audit.
    • Zhangmen Education Inc. (NYSE:ZME) dropped 28.7% to settle at $6.05.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) fell 24% to close at $1.90 after jumping 34% on Wednesday.
    • CNFinance Holdings Limited (NYSE:CNF) dropped 20.3% to settle at $2.99.
    • Longeveron Inc. (NASDAQ:LGVN) fell 18.9% to close at $13.70.
    • Nuverra Environmental Solutions, Inc. (NYSE:NES) dipped 18.6% to settle at $2.01. Nuverra Environmental Solutions recently entered into merger agreement with Select Energy Services.
    • Quidel Corporation (NASDAQ:QDEL) dipped 17.4% to close at $137.39 after the company announced it will acquire Ortho Clinical Diagnostics for $24.68 per share in cash and stock.
    • Acasti Pharma Inc. (NASDAQ:ACST) fell 17.2% to settle at $1.40. Acasti Pharma jumped over 52% on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $6 price target.
    • Hyperfine Inc. (NASDAQ:HYPR) dropped 15.8% to close at $9.19.
    • Evelo Biosciences, Inc. (NASDAQ:EVLO) declined 15.1% to settle at $6.79. Evelo Bio’s 8-K showed that the company gave planned updates to study protocol for Phase 2 trial of EDP1815 in atopic dermatitis.
    • Codex DNA, Inc. (NASDAQ:DNAY) dropped 14.4% to close at $6.31. Codex DNA highlighted release of new full-length synthetic genome of SARS-CoV-2 virus for omicron.
    • GreenPower Motor Company Inc. (NASDAQ:GP) fell 13.1% to close at $8.86.
    • SciPlay Corporation (NASDAQ:SCPL) fell 12.8% to close at $13.49 after the company reported its independent special committee was unable to reach a deal with Scientific Games.
    • Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) dropped 12.4% to close at $3.66.
    • Lilium N.V. (NASDAQ:LILM) dropped 12.2% to close at $7.83 after climbing around 15% on Wednesday.
    • Crocs, Inc. (NASDAQ:CROX) fell 11.6% to close at $123.53 after the company announced the acquisition of HEYDUDE for $2.5 billion.
    • NEXGEL, Inc. (NASDAQ:NXGL) dropped 11.4% to settle at $3.12. The company recently priced its IPO at $5.50 per share.
    • Reliance Global Group, Inc. (NASDAQ:RELI) fell 10.7% to close at $4.32. Reliance Global Group recently announced definitive agreement to acquire Medigap Health Insurance Company for $19.6 million in cash and stock.
    • Willdan Group, Inc. (NASDAQ:WLDN) fell 10.6% to close at $32.08. Willdan recently won a $90 million contract to reduce greenhouse gas emissions in New York Housing.
    • Mission Produce, Inc. (NASDAQ:AVO) shares fell 8.5% to close at $15.82 after the company reported weaker-than-expected results for its fourth quarter on Wednesday.
    • TMC the metals company Inc. (NASDAQ:TMC) dropped 8.1% to close at $2.05.
    • JD.com, Inc. (NASDAQ:JD) fell 6.9% to close at $68.65 after Tencent said it will distribute the majority of its shares in JD.com, valued at HKD 127.7 billion ($16.4 billion), to its shareholders as an interim dividend, effectively diluting its stake in JD.Com from around 17% to about 2.3%.
    Get the next $ACHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHR
    $ACST
    $ALLK
    $AVCT

    CompanyDatePrice TargetRatingAnalyst
    JD.com Inc.
    $JD
    4/17/2026Neutral → Buy
    Arete
    JD.com Inc.
    $JD
    4/14/2026Neutral → Outperform
    Macquarie
    Crocs Inc.
    $CROX
    4/14/2026$135.00Neutral → Buy
    Seaport Research Partners
    Willdan Group Inc.
    $WLDN
    4/9/2026$110.00Outperform
    Wedbush
    Crocs Inc.
    $CROX
    3/10/2026Neutral
    BTIG Research
    NextDecade Corporation
    $NEXT
    3/5/2026$7.00 → $6.00Hold
    TD Cowen
    Crocs Inc.
    $CROX
    2/13/2026$100.00 → $130.00Buy
    Monness Crespi & Hardt
    NextDecade Corporation
    $NEXT
    2/6/2026$7.00Overweight
    CapitalOne
    More analyst ratings

    $ACHR
    $ACST
    $ALLK
    $AVCT
    SEC Filings

    View All

    SEC Form DEFA14A filed by Willdan Group Inc.

    DEFA14A - Willdan Group, Inc. (0001370450) (Filer)

    4/24/26 4:26:26 PM ET
    $WLDN
    Military/Government/Technical
    Consumer Discretionary

    SEC Form DEF 14A filed by Willdan Group Inc.

    DEF 14A - Willdan Group, Inc. (0001370450) (Filer)

    4/24/26 4:25:35 PM ET
    $WLDN
    Military/Government/Technical
    Consumer Discretionary

    SEC Form DEF 14A filed by NextDecade Corporation

    DEF 14A - NextDecade Corp (0001612720) (Filer)

    4/23/26 5:17:57 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    $ACHR
    $ACST
    $ALLK
    $AVCT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operations Officer Mclellan Philip D. was granted 3,238 shares and covered exercise/tax liability with 1,162 shares, increasing direct ownership by 11% to 21,250 units (SEC Form 4) (for tax liability)

    4 - QuidelOrtho Corp (0001906324) (Issuer)

    4/24/26 4:07:54 PM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    EVP Global Port. Mgmt & Mkting Hanson Bryan Michael was granted 3,508 shares and covered exercise/tax liability with 1,269 shares, increasing direct ownership by 249% to 3,139 units (SEC Form 4) to cover taxes

    4 - QuidelOrtho Corp (0001906324) (Issuer)

    4/24/26 4:07:20 PM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form 4 filed by Chief Administrative Officer England Kristin

    4 - Oncology Institute, Inc. (0001799191) (Issuer)

    4/23/26 9:25:46 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    $ACHR
    $ACST
    $ALLK
    $AVCT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Chernett Jorey bought $1,225,101 worth of shares (398,985 units at $3.07), increasing direct ownership by 4% to 10,251,929 units (SEC Form 4)

    4 - Oncology Institute, Inc. (0001799191) (Issuer)

    3/17/26 7:40:00 PM ET
    $TOI
    Medical/Nursing Services
    Health Care

    Large owner Globalharvest Holdings Venture Ltd bought $2,583,903 worth of shares (217,274 units at $11.89), increasing direct ownership by 2% to 9,987,882 units (SEC Form 4)

    4 - Mission Produce, Inc. (0001802974) (Issuer)

    3/17/26 4:54:51 PM ET
    $AVO
    Farming/Seeds/Milling
    Consumer Staples

    Amendment: Chief Financial Officer Busky Joseph M. bought $79,742 worth of shares (3,370 units at $23.66) (SEC Form 4)

    4/A - QuidelOrtho Corp (0001906324) (Issuer)

    2/19/26 4:18:05 PM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ACHR
    $ACST
    $ALLK
    $AVCT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACHR
    $ACST
    $ALLK
    $AVCT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    JD.com upgraded by Arete

    Arete upgraded JD.com from Neutral to Buy

    4/17/26 9:26:04 AM ET
    $JD
    Other Specialty Stores
    Consumer Discretionary

    JD.com upgraded by Macquarie

    Macquarie upgraded JD.com from Neutral to Outperform

    4/14/26 2:47:39 PM ET
    $JD
    Other Specialty Stores
    Consumer Discretionary

    Crocs upgraded by Seaport Research Partners with a new price target

    Seaport Research Partners upgraded Crocs from Neutral to Buy and set a new price target of $135.00

    4/14/26 8:12:23 AM ET
    $CROX
    Shoe Manufacturing
    Consumer Discretionary

    $ACHR
    $ACST
    $ALLK
    $AVCT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Understanding and Addressing Syphilis Trends - and What's Being Missed

    SAN DIEGO, April 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (NASDAQ:QDEL), a global leader of in vitro diagnostics, has released episode 57 of its Science Bytes podcast, focusing on evolving syphilis trends in the United States and the rise of congenital syphilis cases despite declines in early-stage infections. Hosted by Josh Casey, the episode features Andrea Ott‑Vasconi, Director of Scientific Affairs and Regulatory at QuidelOrtho, who breaks down what CDC data reveals, why congenital syphilis continues to rise and how diagnostic strategies and healthcare workflows can

    4/23/26 9:32:00 AM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    ESS to Host First Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026 at 5:00 p.m. Eastern Time

    ESS Tech, Inc. (ESS) (NYSE: GWH), a leading manufacturer of iron flow long-duration energy storage (LDES) systems for commercial- and utility-scale applications, today announced that it will hold a conference call on Thursday, May 7, 2026 at 5:00 p.m. EDT to discuss financial results for its first quarter 2026 ended March 31, 2026, and will be providing updates on commercial progress, customer deployments, and anticipated technology milestones. A press release detailing these results will be issued prior to the call. ESS Tech CEO Drew Buckley and CFO Kate Suhadolnik will host the conference call, followed by a question-and-answer period. The conference call will be accompanied by a presen

    4/23/26 8:31:00 AM ET
    $GWH
    Industrial Machinery/Components
    Miscellaneous

    22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State University

    MOCKSVILLE, N.C., April 23, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), a tobacco products company focused on nicotine reduction and plant biotechnology, today announced corporate updates regarding a new testing services agreement with North Carolina State University aimed at validating tobacco varieties featuring improved leaf quality and increased crop yields with the same low-nicotine content. The initiative builds upon 22nd Century's proprietary reduced nicotine content technology platform, which utilizes advanced plant breeding and biotechnology to reduce nicotine content in tobacco to minimally addictive levels. The Company's reduced nicotine tobacco is the foun

    4/23/26 7:50:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACHR
    $ACST
    $ALLK
    $AVCT
    Leadership Updates

    Live Leadership Updates

    View All

    QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics

    – Marks a Milestone in QuidelOrtho's Plans to Accelerate Growth in Point-of-Care Molecular Diagnostics –– Expands Portfolio with Ultra-Fast PCR Platform Designed to Deliver Results in Approximately Ten Minutes or Less –– Company Expects to Initiate U.S. Commercial Launch of the LEX VELO System Later This Year –SAN DIEGO, April 20, 2026 /PRNewswire/ -- QuidelOrtho Corporation (NASDAQ:QDEL) (the "Company" or "QuidelOrtho"), a global leader of innovative in vitro diagnostics, announced today it has completed the acquisition of LEX Diagnostics ("LEX") for cash consideration of approximately $100 million. The LEX VELO System received U.S. Food and Drug Administration ("FDA") 510(k) clearance and

    4/20/26 7:12:00 AM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

    WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced the appointment of Cheryl R. Blanchard, Ph.D. to the company's board of directors. The company also announced that Christina Rossi has stepped down from its board of directors, effective April 15, 2026. "Cheryl brings over three decades of leadership experience advancing the development of innovative products across biologics, small molecules and medical devices, and I am pleased to welcome her to the board," said Sara Bonstein, chair of the board of direct

    4/16/26 7:30:00 AM ET
    $ANIK
    $XLO
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Inspira Technologies Appoints Yoav Rozanovich as Chief Business Officer to Drive Immediate Revenue Growth and Quantum Expansion

    RA'ANANA, Israel, April 14, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd (NASDAQ:IINN, IINNW)) ("Inspira Technologies" or the "Company") today announced the appointment of Mr. Yoav Rozanovich as Chief Business Officer ("CBO") of Inspira Technologies, reinforcing its commercial execution capabilities following its expansion into quantum computing connectivity and the acquisition of the Additive Manufacturing of Electronics ("AME") business from Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension"). Proven Commercial LeadershipMr. Rozanovich brings international experience across additive manufacturing, advanced electronics, and complex systems integration. From November 2021

    4/14/26 8:01:00 AM ET
    $IINN
    $NNDM
    $SSYS
    Medical/Dental Instruments
    Health Care
    Electrical Products
    Technology

    $ACHR
    $ACST
    $ALLK
    $AVCT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by QuidelOrtho Corporation

    SC 13G/A - QuidelOrtho Corp (0001906324) (Subject)

    12/6/24 10:11:24 AM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13D/A filed by QuidelOrtho Corporation

    SC 13D/A - QuidelOrtho Corp (0001906324) (Subject)

    11/21/24 5:10:19 PM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ACHR
    $ACST
    $ALLK
    $AVCT
    Financials

    Live finance-specific insights

    View All

    ESS to Host First Quarter 2026 Financial Results Conference Call on Thursday, May 7, 2026 at 5:00 p.m. Eastern Time

    ESS Tech, Inc. (ESS) (NYSE: GWH), a leading manufacturer of iron flow long-duration energy storage (LDES) systems for commercial- and utility-scale applications, today announced that it will hold a conference call on Thursday, May 7, 2026 at 5:00 p.m. EDT to discuss financial results for its first quarter 2026 ended March 31, 2026, and will be providing updates on commercial progress, customer deployments, and anticipated technology milestones. A press release detailing these results will be issued prior to the call. ESS Tech CEO Drew Buckley and CFO Kate Suhadolnik will host the conference call, followed by a question-and-answer period. The conference call will be accompanied by a presen

    4/23/26 8:31:00 AM ET
    $GWH
    Industrial Machinery/Components
    Miscellaneous

    The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial

    Issued on behalf of Avaí Bio, Inc. Companies mentioned in this commentary include: Avaí Bio, Inc. (OTCQB:AVAI), Eli Lilly and Company (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), Viking Therapeutics, Inc. (NASDAQ:VKTX), Longeveron Inc. (NASDAQ:LGVN). Key Takeaways: The global anti-aging market generated more than $85 billion in 2025 and is projected to approach $120 billion by 2030, with private investment in longevity science more than doubling to $8.49 billion across 325 deals last year.The U.S. FDA approved 50 new drugs in 2024 and 46 in 2025 — including what researchers are calling the first drug class of "longevity therapeutics" — while big pharma spent more than $65 billion acquiring bi

    4/23/26 6:15:00 AM ET
    $LGVN
    $LLY
    $NVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    InnovAge to Announce Fiscal Third Quarter 2026 Financial Results and Host Conference Call Tuesday, May 5, 2026

    DENVER, April 21, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2026 fiscal third quarter financial results on Tuesday, May 5, 2026, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T. on the same day. Conference Call DetailsA live audio webcast of the call will be available on the Company's website, https://investor.innovage.com/. A replay of the call will be availabl

    4/21/26 8:00:00 AM ET
    $INNV
    Medical/Nursing Services
    Health Care